BioLife Solutions Inc (BLFS)

Return on equity (ROE)

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Net income (ttm) US$ in thousands -66,427 -102,234 -83,419 -146,098 -139,805 -106,361 -95,965 -15,211 -8,908 4,025 2,813 -21,443 1,983 7,778 19,180 39,812 -1,657 16,293 -18,441 -49,039
Total stockholders’ equity US$ in thousands 337,663 332,017 352,128 358,107 364,188 405,120 409,544 476,075 478,047 489,259 452,281 208,777 204,429 186,851 105,843 67,709 43,321 35,191 2,072 -3,740
ROE -19.67% -30.79% -23.69% -40.80% -38.39% -26.25% -23.43% -3.20% -1.86% 0.82% 0.62% -10.27% 0.97% 4.16% 18.12% 58.80% -3.82% 46.30% -890.01%

December 31, 2023 calculation

ROE = Net income (ttm) ÷ Total stockholders’ equity
= $-66,427K ÷ $337,663K
= -19.67%

The return on equity (ROE) for BioLife Solutions Inc has shown significant fluctuations over the past few quarters, ranging from -890.01% to 58.80%. The ROE has been negative in most recent quarters, indicating that the company's net income is not sufficient to generate a positive return for its shareholders.

The ROE has been particularly low in the last four quarters, with values below -20%, reaching as low as -40.80%. These results suggest that the company's profitability and efficiency in generating returns for its shareholders have been under pressure.

It is important for investors to closely monitor the company's financial performance and management strategies to assess its ability to improve ROE in the future. The negative and fluctuating ROE trends may raise concerns about the company's overall financial health and sustainability.


Peer comparison

Dec 31, 2023